XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity Method Investments, Investment in Arbutus (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Investments [Abstract]          
Number of shares acquired (in shares) 804,890,910   804,890,910   760,143,393
Aggregate fair value investment $ 239,927   $ 239,927   $ 304,317
Arbutus Biopharma Corporation [Member]          
Investments [Abstract]          
Equity method investment ownership percentage 23.00%   23.00%    
Aggregate fair value investment $ 97,100   $ 97,100   $ 117,700
Unrealized gain (losses) on investments $ 18,300 $ 16,300 $ (20,600) $ (25,300)  
Closing price of common stock (in dollars per share) $ 2.5   $ 2.5   $ 3.03
Arbutus Biopharma Corporation [Member] | Common Stock [Member]          
Investments [Abstract]          
Number of shares acquired (in shares) 38,847,462   38,847,462